Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by hemi3tcon Jul 07, 2021 1:03am
249 Views
Post# 33503914

RE:5 things to like about Ventripoint

RE:5 things to like about Ventripoint But even as good as VMS 3.0 plus sound and with CE and FDA approval  to sell.
Sales targets were never met.     Also after almost 3 years   still on VMS 3.0+


Ventripoint readies sales push of 3D heart imaging VMS+ 3.0 device
November 19, 2019
Mr. Leushner says Ventripoint’s VMS technology has been published in more than 60 peer-reviewed publications, which validated the technology and was part of the company’s regulatory evidence.
 
“Our short-term goal is to install 70 systems by the end of 2020, climbing to 400 by the end of year three, so system sales and recurring revenue from software and upgrades are compelling to potential partners,” he contends.

 

Longtermbuyer12 wrote: Just came across this great article from Small Cap Asia 
https://www.smallcapasia.com/5-things-to-like-about-ventripoint/
The comparison they did says it all: 

The story wouldn’t be complete if you don’t compare the company against its peers. Hence, we decided to pit Ventripoint against Nasdaq-listed Nano X- Imaging Ltd. (NNOX) with a market cap of US$1.57 Billion.

I really don't regret having been a long term investor of VTP as the growth opportunity is great
Looking forward to it


<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse